Organic CBG (Cannabigerol)

Medicinal Organic Cannabis (MOCA) is excited to introduce our fully organic crop of Cannabigerol (CBG) to the Australian market. CBG is one of over 120 types of cannabinoids found in the cannabis plant, and is known as the “mother of all cannabinoids”. Our CBG is grown using sustainable and organic practices and is now available for purchase by compounding pharmacies in Australia.

Medicinal Organic Cannabis Australia (MOCA) has completed its harvest of  organic CBG (Cannabigerol). 

CBG is processed by the body’s endocannabinoid system, which is responsible for keeping our bodies in an optimal state. Research has shown that CBG may have a host of promising potential benefits. These include, but are not limited to:

Organic CBG produced by Medicinal Organic Cannabis Australia.

Our beautiful organic CBG flowers.

Medicinal Organic Cannabis Australia (MOCA)

Australia's first Medical Organic Cannabis Company

In the past, CBG was mainly known as a “minor cannabinoid”. However, recent research has shown that it is present in high percentages in the cannabis plant at the beginning of the flowering phase. It is also the first substance to develop in the plant, in the acid form CBGA. It is from CBGA that other cannabinoids such as THC and CBD are derived.

The production difficulties of CBG make it very scarce. It is much harder to produce than other cannabinoids like THC and CBD. Since CBG shares many similarities with CBD, manufacturers would rather produce CBD. However, MOCA is committed to producing CBG using sustainable and organic practices, and we believe that it has the potential to be an important cannabinoid in the medical cannabis industry.

Our CBG is grown using the “seed to sale” approach, which means that we are involved in all aspects of the supply chain. This allows us to ensure that our manufacturing meets our standards and vision. Our commitment to sustainability is also reflected in our business model, which is based on the three P’s - People, Planet, and Profit. We consider this the ethical measure of businesses, and our investment principles take into account the impact on the environment, the social perspective, and our corporate governance.

At MOCA, we believe that sustainability is the future, and with our unique mix of experience and skills, our sustainable management team of professionals can build some of the most prosperous triple bottom line companies in the world. Our triple bottom line accounting expands the traditional reporting framework to take into account social and environmental performance in addition to financial performance.

In conclusion, MOCA’s fully organic crop of Cannabigerol (CBG) is a promising addition to the medical cannabis industry. As research into the potential benefits of CBG continues, we believe that it has the potential to be an important cannabinoid in the treatment of a range of medical conditions. Our commitment to sustainability and organic practices ensures that our CBG is of the highest quality, and we are excited to offer it to compounding pharmacies in Australia.

Cannabigerol organically grown by Organic CBG produced by Medicinal Organic Cannabis Australia.

Cannabigerol organically grown by Medicinal Organic Cannabis Australia.


Please note that while these references support the health properties of CBG, it is important to consult with a healthcare professional for personalized advice and guidance regarding the use of CBG or any other cannabinoid for specific health conditions.